Clinical Trial

Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients

Name: Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients — clinical trial record (NCT06234072)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study compare the efficacy of Astragalus combined with Gemcitabine to Gemcitabine alone as neoadjuvant treatment for pancreatic cancer.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-01-22.

Trial Details

NCT Number	NCT06234072
Lead Sponsor	Shenzhen University General Hospital
Conditions	Pancreatic Cancer
Enrollment	120 participants
Start Date	2024-02
Primary Completion	2027-01 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2024-02-02